Aerpio Pharmaceuticals, Inc. (ARPO) financial statements (2021 and earlier)

Company profile

Business Address 9987 CARVER ROAD
CINCINNATI, OH 45242
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments43396320000
Cash and cash equivalents43396320000
Prepaid expense1010   
Other current assets2110   
Total current assets:45406421000
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0000   
Deposits noncurrent assets0000   
Total noncurrent assets:0000   
TOTAL ASSETS:45406421000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2354000
Accounts payable1011000
Accrued liabilities0010000
Employee-related liabilities0121   
Interest and dividends payable    000
Other undisclosed accounts payable and accrued liabilities0221   
Debt 0     
Due to related parties    000
Other undisclosed current liabilities0      
Total current liabilities:2354000
Noncurrent Liabilities
Long-term debt and lease obligation 0     
Operating lease, liability 0
Total noncurrent liabilities: 0     
Total liabilities:2354000
Stockholders' equity
Stockholders' equity attributable to parent, including:43375917(0)(0)(0)
Common stock0000000
Additional paid in capital190179178126000
Accumulated deficit(147)(142)(119)(109)(0)(0) 
Other undisclosed stockholders' equity attributable to parent      (0)
Total stockholders' equity:43375917(0)(0)(0)
TOTAL LIABILITIES AND EQUITY:45406421000

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:15 20    
Operating expenses(21)(24)(31)(21)(0)(0)(0)
Operating loss:(6)(24)(11)(21)(0)(0)(0)
Nonoperating income (expense)211(0)   
Other nonoperating income2      
Interest and debt expense   (0)(0)(0)(0)
Net loss:(4)(23)(10)(21)(0)(0)(0)
Other undisclosed net income attributable to parent   0   
Net loss attributable to parent:(4)(23)(10)(21)(0)(0)(0)
Preferred stock dividends and other adjustments   (1)   
Net loss available to common stockholders, diluted:(4)(23)(10)(22)(0)(0)(0)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(4)(23)(10)(21)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(4)(23)(10)(21)(0)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: